A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Dexcom Inc stock. As of the latest transaction made, Renaissance Technologies LLC holds 830,972 shares of DXCM stock, worth $60.5 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
830,972
Previous 462,572 79.64%
Holding current value
$60.5 Million
Previous $52.4 Million 6.19%
% of portfolio
0.09%
Previous 0.09%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$64.0 - $116.06 $23.6 Million - $42.8 Million
368,400 Added 79.64%
830,972 $55.7 Million
Q2 2024

Aug 09, 2024

SELL
$110.31 - $140.45 $42.5 Million - $54.1 Million
-385,100 Reduced 45.43%
462,572 $52.4 Million
Q1 2024

May 13, 2024

BUY
$114.22 - $140.1 $96.5 Million - $118 Million
844,972 Added 31295.26%
847,672 $118 Million
Q4 2023

Feb 13, 2024

BUY
$75.49 - $124.16 $203,823 - $335,232
2,700 New
2,700 $335,000
Q2 2023

Aug 11, 2023

SELL
$112.47 - $130.98 $13.7 Million - $15.9 Million
-121,600 Reduced 41.9%
168,600 $21.7 Million
Q1 2023

May 12, 2023

BUY
$104.0 - $122.92 $22.1 Million - $26.2 Million
212,900 Added 275.42%
290,200 $33.7 Million
Q4 2022

Feb 13, 2023

BUY
$84.98 - $122.67 $6.07 Million - $8.76 Million
71,400 Added 1210.17%
77,300 $8.75 Million
Q3 2022

Nov 14, 2022

SELL
$76.35 - $94.18 $67.9 Million - $83.7 Million
-888,672 Reduced 99.34%
5,900 $475,000
Q2 2022

Aug 12, 2022

BUY
$67.99 - $132.89 $59.2 Million - $116 Million
871,372 Added 3755.91%
894,572 $66.7 Million
Q1 2022

May 13, 2022

SELL
$94.08 - $130.2 $11 Million - $15.2 Million
-116,743 Reduced 83.42%
23,200 $11.9 Million
Q4 2021

Feb 11, 2022

BUY
$129.87 - $162.82 $18.2 Million - $22.8 Million
139,943 New
139,943 $75.1 Million
Q2 2021

Aug 13, 2021

SELL
$80.99 - $107.93 $11.7 Million - $15.5 Million
-144,043 Closed
0 $0
Q1 2021

May 13, 2021

SELL
$84.79 - $104.74 $12 Million - $14.8 Million
-140,966 Reduced 49.46%
144,043 $51.8 Million
Q4 2020

Feb 10, 2021

SELL
$78.0 - $104.5 $34.9 Million - $46.7 Million
-446,967 Reduced 61.06%
285,009 $105 Million
Q3 2020

Nov 13, 2020

SELL
$95.51 - $112.95 $43.1 Million - $51 Million
-451,100 Reduced 38.13%
731,976 $302 Million
Q2 2020

Aug 13, 2020

BUY
$62.68 - $105.34 $14.7 Million - $24.6 Million
233,747 Added 24.62%
1,183,076 $480 Million
Q1 2020

May 14, 2020

BUY
$47.79 - $75.63 $11.9 Million - $18.8 Million
249,086 Added 35.57%
949,329 $256 Million
Q4 2019

Feb 13, 2020

BUY
$36.62 - $57.29 $23.6 Million - $36.9 Million
644,843 Added 1163.98%
700,243 $153 Million
Q3 2019

Nov 13, 2019

SELL
$35.53 - $43.8 $8.72 Million - $10.8 Million
-245,543 Reduced 81.59%
55,400 $8.27 Million
Q2 2019

Aug 12, 2019

SELL
$27.84 - $38.92 $26.8 Million - $37.4 Million
-961,198 Reduced 76.16%
300,943 $45.1 Million
Q1 2019

May 14, 2019

BUY
$28.07 - $38.18 $8.07 Million - $11 Million
287,553 Added 29.51%
1,262,141 $150 Million
Q4 2018

Feb 13, 2019

BUY
$26.99 - $37.37 $26.3 Million - $36.4 Million
974,588 New
974,588 $117 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $28.1B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.